Tilray Inc (TLRY)

HEALTH CARE: PHARMACEUTICALS
SIC: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS

1100 MAUGHAN ROAD NANAIMO, BRITISH COLUMBIA, CANADA V9X 1J2

Tilray, Inc. operates as a pharmaceutical company. The Company develops cannabis based medicines, drugs, drops, and oil products. Tilray serves clients worldwide.

Data as of 2020-07-04
Market Cap869.039 Million Shares Outstanding124.862 Million Avg 30-day Volume11.018 Million
P/E Ratio Dividend Yield EPS-4.61
Price/Sales5.016 Price cash flow ratio Price free cash flow ratio-2.7
Book Value1.52 Price to Tangible Book-5.85 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low48.48 / 2.43 Stddev
View SEC Filings from TLRY instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 1 3 (0.2%)
13F Filers holding this stock: 169 31 (2.03%)
Aggregate 13F shares on 03/31/2020: 9.929 Million 2.099 Million
Aggregate 13F shares on 12/31/2019: 10.588 Million 2.629 Million
Percent change: -6.22% -20.14%
Funds creating new positions: 44 10
Funds Adding to an existing position: 45 8
Funds closing out their position: 34 10
Funds reducing their position: 33 10
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TLRY (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TLRY BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

350 Thousand total shares from 3 transactions

Exercise Derivative Conversion (M)

43.5 Thousand total shares from 8 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

PUCHER ANDREW CHIEF CORPORATE DEV OFFICER

  • Officer
17,440 2020-06-18 4

KENNEDY BRENDAN PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
4,358,207 2020-06-16 10

AUERBACH MICHAEL

  • Director
1,698,476 2020-06-05 9

DOPP REBEKAH

  • Director
0 2020-06-05 5

ST.CLARE CHRISTINE

  • Director
0 2020-06-05 5

GREENWOOD MARYSCOTT

  • Director
0 2020-06-05 5

DICKSON KATHRYN P

  • Director
0 2020-05-08 2

PASTORIUS EDWARD WOOD JR CHIEF REVENUE OFFICER

  • Officer
0 2020-04-17 5

LEVIN JON EDWARD CHIEF OPERATING OFFICER

  • Officer
0 2020-03-05 2

KRUTECK MICHAEL C. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-05 2

CASTANEDA MARK CFO, SECRETARY, TREASURER

  • Officer
129,505 2019-07-18 1

PRIVATEER HOLDINGS, INC.

  • 10% Owner
75,000,000 2018-07-18 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PUCHER ANDREW - Officer CHIEF CORPORATE DEV OFFICER

2020-06-18 M 7,497 a 21,449 17,440.00 direct

PUCHER ANDREW - Officer CHIEF CORPORATE DEV OFFICER

2020-06-18 M 7,497 d 52,479 17,440.00 direct

KENNEDY BRENDAN - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-06-18 S 116,668 $8.22 d 4,281,793 4,358,207.00 direct

PUCHER ANDREW - Officer CHIEF CORPORATE DEV OFFICER

2020-06-18 F 4,009 d 17,440 17,440.00 direct

KENNEDY BRENDAN - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-06-17 S 116,666 $8.04 d 4,398,461 4,358,207.00 direct

KENNEDY BRENDAN - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-06-16 S 116,666 $8.34 d 4,515,127 4,358,207.00 direct

KENNEDY BRENDAN - Director - Officer - > 10% Owner PRESIDENT AND CEO

2020-06-12 A 110,974 a 110,974 0.00 direct

DOPP REBEKAH - Director

2020-06-05 A 26,372 a 26,372 0.00 direct

AUERBACH MICHAEL - Director by: m3 daat, llc

2020-06-05 J 10,475 a 75,525 1,698,476.00 indirect

AUERBACH MICHAEL - Director by: murphy ofutt llc

2020-06-05 J 538,706 d 128,319 1,698,476.00 indirect

GREENWOOD MARYSCOTT - Director

2020-06-05 A 26,372 d 26,372 0.00 direct

AUERBACH MICHAEL - Director by: murphy ofutt common llc

2020-06-05 J 210,710 a 1,494,632 1,698,476.00 indirect

ST.CLARE CHRISTINE - Director

2020-06-05 A 26,372 a 26,372 0.00 direct

AUERBACH MICHAEL - Director

2020-06-05 A 26,372 a 26,372 1,698,476.00 direct

AUERBACH MICHAEL - Director by: m3 daat, llc

2020-06-05 J 57,159 a 65,050 1,698,476.00 indirect

GREENWOOD MARYSCOTT - Director

2020-06-01 M 2,188 a 24,204 24,204.00 direct

ST.CLARE CHRISTINE - Director

2020-06-01 M 2,188 a 20,871 20,871.00 direct

GREENWOOD MARYSCOTT - Director

2020-06-01 M 2,188 d 17,500 24,204.00 direct

ST.CLARE CHRISTINE - Director

2020-06-01 M 2,188 d 17,500 20,871.00 direct

DOPP REBEKAH - Director

2020-06-01 M 2,188 a 20,933 20,933.00 direct

DOPP REBEKAH - Director

2020-06-01 M 2,188 d 17,500 20,933.00 direct

DOPP REBEKAH - Director

2020-05-28 M 7,371 a 18,745 20,933.00 direct

AUERBACH MICHAEL - Director

2020-05-28 M 7,371 a 393,256 2,773,514.00 direct

DOPP REBEKAH - Director

2020-05-28 M 7,371 d 0 20,933.00 direct

GREENWOOD MARYSCOTT - Director

2020-05-28 M 7,371 a 22,016 24,204.00 direct

ST.CLARE CHRISTINE - Director

2020-05-28 M 7,371 a 18,683 20,871.00 direct

GREENWOOD MARYSCOTT - Director

2020-05-28 M 7,371 d 0 24,204.00 direct

AUERBACH MICHAEL - Director

2020-05-28 M 7,371 d 0 2,773,514.00 direct

ST.CLARE CHRISTINE - Director

2020-05-28 M 7,371 d 0 20,871.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments